RxDoctor Payments Data

Shakuntala Jain, MD

Psychiatry · Phoenix, AZNPI 1629157771

Payments from drug & device makers

$2,172in general payments, 2019–2025

Across 98 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$400
  • Johnson & Johnson$322
  • Alkermes, Inc.$286
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$210
  • Neurocrine Biosciences, Inc.$193
  • AbbVie$187
  • plus $575 from 7 others

What the payments were for

  • Food & beverage$2,11197%
  • Education$613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,172 in reported general payments places this provider in the 80th percentile of 573 psychiatry providers in Arizona.

See all psychiatry providers in Arizona

Medicare billing

Part B allowed, 2024
$13,492
Medicare patients
27
Services billed
133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl149$178,034
Invega SustennaPaliperidone Palmitate25$79,983
Abilify MaintenaAripiprazole26$62,667
VivitrolNaltrexone Microspheres12$21,544
Quetiapine Fumarate98$3,016
Clozapine61$2,669
Carbamazepine ErCarbamazepine19$2,089
Ziprasidone Hcl39$1,708
Aripiprazole24$1,607
Bupropion XlBupropion Hcl81$1,493
Duloxetine Hcl40$1,408
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine33$1,345
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine14$1,303
Buspirone Hcl76$1,149
Gabapentin58$966

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato, Invega Sustenna$322$258,017174 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$168$62,66726 claims
Alkermes, Inc.Vivitrol$286$21,54412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 573 psychiatry providers in Arizona.

Other psychiatry in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →